NORTH AMERICA BIOCHIPS MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

NORTH AMERICA BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Material, End Users, And Geography | Forecasts 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The North America biochips market is expected to display an upward trend and is estimated to grow at a CAGR of 19.57% during the forecasted years of 2019-2027. 

The countries covered in the North America biochips market are:

o          United States

o          Canada

Biochips are microarray that has the ability to perform thousands of concurrent biochemical reactions. It is a cluster of microarrays that are organized on the top of a solid substrate. Biochips are designed in such a way that it can be used to execute multiple tests simultaneously to achieve greater pace and throughput.

North America biochips market is expected to display an upward trend and is estimated to grow at a CAGR of 19.57%

We provide additional customization based on your specific requirements. Request For Customization  

The biochips market report is segmented on the basis of type, substrate material, and end users. The United States and Canada are the prime countries driving the biochips market in the region. The U.S biochips market produced the highest revenue in 2018 and is anticipated to make continuous progress throughout the forecasting years.

The biochips market report by Triton consists detailed information about the regulatory framework, the evolution & transition of biochips, key market analysis of biochips market, the value chain outlook, Porter’s five force analysis, the market attractiveness matrix, vendor scorecard, key impact analysis, industrial player positioning, and key market strategies.

The U.S biochips market is driven by the increasing choice for personalized medicines for the exact treatment of diseases such as asthma, diabetes, cancer, etc. The Canadian biochips market is driven by subsidies from the Ontario Health Innovation Council for the research & development in the field of biotech and life science.

The development in technology is also expected to augment the growth of the biochips market in the coming years. The restraining factors such as inadequate technical awareness related to biochips and complexity of biological systems are obstructing the growth of the biochips market in the North American region.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT

Table of Content

1.    BIOCHIPS MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.3. EVOLUTION & TRANSITION OF BIOCHIPS

2.4. PORTER'S FIVE FORCE ANALYSIS

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY IMPACT ANALYSIS

2.10.            MARKET OPPORTUNITY INSIGHTS

2.11.            INDUSTRY PLAYER POSITIONING

2.12.            KEY MARKET STRATEGIES

2.13.            MARKET DRIVERS

2.13.1.                GROWTH IN PERSONALIZED MEDICINES

2.13.2.                RISING INCIDENCES & TREATMENT OF CANCER

2.13.3.                CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE

2.13.4.                INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D

2.14.            MARKET RESTRAINTS

2.14.1.                INEQUALITY IN HEALTHCARE ACCESS

2.14.2.                INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS

2.14.3.                COMPLEXITY OF BIOLOGICAL SYSTEMS

2.15.            MARKET OPPORTUNITIES

2.15.1.                DEVELOPMENTS IN BIOCHIPS TECHNOLOGY

2.15.2.                WIDENING APPLICATION AREAS OF BIOCHIPS

2.16.            MARKET CHALLENGES

2.16.1.                AVAILABILITY OF SUBSTITUTE TECHNOLOGIES

2.16.2.                UNCLEAR REGULATORY GUIDELINES

2.16.3.                COST CONSTRAINTS

3.    BIOCHIPS INDUSTRY OUTLOOK – BY TYPE

3.1. DNA CHIPS

3.1.1.   AGRICULTURAL BIOTECHNOLOGY

3.1.2.   CANCER DIAGNOSTICS & TREATMENT

3.1.3.   DRUG DISCOVERY

3.1.4.   GENE EXPRESSION

3.1.5.   GENOMICS

3.1.6.   SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING

3.1.7.   OTHER DNA CHIPS

3.2. LAB ON A CHIP

3.2.1.   CLINICAL DIAGNOSTICS

3.2.2.   DRUG DISCOVERY

3.2.3.   GENOMICS

3.2.4.   POINT OF CARE & IN VITRO DIAGNOSIS

3.2.5.   PROTEOMICS

3.2.6.   OTHER LAB ON A CHIP

3.3. PROTEIN CHIPS

3.3.1.   DIAGNOSTICS

3.3.2.   DRUG DISCOVERY

3.3.3.   EXPRESSION PROFILING

3.3.4.   HIGH THROUGHPUT SCREENING

3.3.5.   PROTEOMICS

3.3.6.   OTHER PROTEIN CHIPS

3.4. OTHER CHIPS

3.4.1.   CELL ARRAYS

3.4.2.   TISSUE ARRAYS

4.    BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL

4.1. GLASS

4.2. POLYMERS

4.3. SILICON

4.4. OTHER SUBSTRATE MATERIALS

5.    BIOCHIPS INDUSTRY OUTLOOK - BY END USER

5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

5.2. HOSPITALS AND DIAGNOSTICS CENTERS

5.3. ACADEMIC AND RESEARCH INSTITUTE

6.    BIOCHIPS INDUSTRY - NORTH AMERICA

6.1. UNITED STATES

6.2. CANADA

7.    COMPETITIVE LANDSCAPE

7.1. AGILENT TECHNOLOGY INC.

7.2. BIOCHAIN INSTITUTE INC.

7.3. BIOMERIEUX SA

7.4. BIO-RAD LABORATORIES INC.

7.5. CEPHEID INC.

7.6. CYBRDI INC.

7.7. FLUIDIGM CORPORATION

7.8. GAMIDA FOR LIFE GROUP

7.9. ILLUMINA INC.

7.10.            IMGENEX

7.11.            MERCK GMBH

7.12.            ORIGENE TECHNOLOGIES INC.

7.13.            PERKINELMER INC.

7.14.            SAMSUNG ELECTRONICS INC.

7.15.            THERMO FISHER SCIENTIFIC INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET       

TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET

TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET

TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET

TABLE 5. ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN THE UNITED STATES IN 2017    

TABLE 6. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017          

TABLE 7. ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)

TABLE 8. ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS)

TABLE 9. NORTH AMERICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 10. NORTH AMERICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)       

TABLE 11. NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)

TABLE 12. NORTH AMERICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1. NORTH AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)  

FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET

FIGURE 3. KEY IMPACT ANALYSIS

FIGURE 4. TIMELINE OF BIOCHIPS

FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018

FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018   

FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET   

FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%)

FIGURE 9. UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)        

FIGURE 10. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE        

FIGURE 11. NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)           

FIGURE 12. NORTH AMERICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)

FIGURE 13. NORTH AMERICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 14. NORTH AMERICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)      

FIGURE 15. NORTH AMERICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)      

FIGURE 16. NORTH AMERICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)      

FIGURE 17. NORTH AMERICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)         

FIGURE 18. NORTH AMERICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)      

FIGURE 19. NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)      

FIGURE 20. NORTH AMERICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 21. NORTH AMERICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 22. NORTH AMERICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)

FIGURE 23. NORTH AMERICA LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION)

FIGURE 24. NORTH AMERICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)      

FIGURE 25. NORTH AMERICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)

FIGURE 26. NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 27. NORTH AMERICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 28. NORTH AMERICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 29. NORTH AMERICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)

FIGURE 30. NORTH AMERICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)

FIGURE 31. NORTH AMERICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)

FIGURE 32. NORTH AMERICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 33. NORTH AMERICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 34. NORTH AMERICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 35. NORTH AMERICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 36. NORTH AMERICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)           

FIGURE 37. NORTH AMERICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)

FIGURE 38. NORTH AMERICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)

FIGURE 39. NORTH AMERICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)

FIGURE 40. NORTH AMERICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)

FIGURE 41. NORTH AMERICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)

FIGURE 42. NORTH AMERICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)

FIGURE 43. NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)           

FIGURE 44. UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 45. CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)     

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;